Literature DB >> 16120397

Developing a systematic approach to the diagnosis and classification of mitochondrial disease.

Robert K Naviaux1.   

Abstract

The accurate diagnosis and classification of mitochondrial diseases are essential first steps in understanding the natural history and true health care burden imposed by these protean and devastating disorders. Epidemiologic studies place the incidence of genetic forms of mitochondrial disease between 1 in 2000 and 1 in 5000 live births. Symptoms may not appear for years after birth, even when inherited. Once they occur, however, the course is often relentlessly progressive. Diagnosis requires a combination of clinical and laboratory studies that are applied systematically. DNA analysis and respiratory chain studies remain the mainstays of diagnosis, but several other disciplines may contribute to achieving diagnostic confidence when a single study is suggestive but inconclusive. A comprehensive classification system for mitochondrial diseases has not yet been developed. The current International Classification of Diseases, 10th Revision (ICD-10) includes just 10 codes for mitochondrial disorders. Supplementary data of 347 proposed ICD-10 codes is included to assist with the development of a more comprehensive system for the diagnosis and classification of mitochondrial disease.

Entities:  

Year:  2004        PMID: 16120397     DOI: 10.1016/j.mito.2004.07.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  15 in total

Review 1.  From serendipity to mitochondria-targeted nanocarriers.

Authors:  Volkmar Weissig
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

Review 2.  Inherited mitochondrial genomic instability and chemical exposures.

Authors:  Sherine S L Chan
Journal:  Toxicology       Date:  2017-07-26       Impact factor: 4.221

3.  New mitochondrial DNA mutations in tRNA associated with three severe encephalopamyopathic phenotypes: neonatal, infantile, and childhood onset.

Authors:  María del Mar O'Callaghan; Sonia Emperador; Ester López-Gallardo; Cristina Jou; Nuria Buján; Raquel Montero; Angels Garcia-Cazorla; Diana Gonzaga; Isidre Ferrer; Paz Briones; Eduardo Ruiz-Pesini; Mercè Pineda; Rafael Artuch; Julio Montoya
Journal:  Neurogenetics       Date:  2012-05-26       Impact factor: 2.660

4.  Saccharomyces cerevisiae polymerase zeta functions in mitochondria.

Authors:  Hengshan Zhang; Aditi Chatterjee; Keshav K Singh
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

5.  Functional analysis of mutant mitochondrial DNA polymerase proteins involved in human disease.

Authors:  Sherine S L Chan; William C Copeland
Journal:  Methods Mol Biol       Date:  2009

6.  Retained features of embryonic metabolism in the adult MRL mouse.

Authors:  Robert K Naviaux; Thuy P Le; Khamilia Bedelbaeva; John Leferovich; Dmitri Gourevitch; Pawel Sachadyn; Xiang-Ming Zhang; Lise Clark; Ellen Heber-Katz
Journal:  Mol Genet Metab       Date:  2009-01-07       Impact factor: 4.797

7.  Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites.

Authors:  Colleen Clarke; Rui Xiao; Emily Place; Zhe Zhang; Neal Sondheimer; Michael Bennett; Marc Yudkoff; Marni J Falk
Journal:  Mol Genet Metab       Date:  2013-07-19       Impact factor: 4.797

Review 8.  Molecular genetic testing for mitochondrial disease: from one generation to the next.

Authors:  Elizabeth McCormick; Emily Place; Marni J Falk
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 9.  Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects.

Authors:  Gerard G M D'Souza; Sarathi V Boddapati; Volkmar Weissig
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.580

10.  Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.

Authors:  Jacqueline R Weissman; Richard I Kelley; Margaret L Bauman; Bruce H Cohen; Katherine F Murray; Rebecca L Mitchell; Rebecca L Kern; Marvin R Natowicz
Journal:  PLoS One       Date:  2008-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.